Image

A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation

Investigational Treatment for Advanced Pancreatic Cancer with KRAS G12V Mutation

Recruiting
18-75 years
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced pancreatic cancer with a specific genetic mutation known as KRAS G12V. The purpose of this study is to explore the effects of an investigational medication.

The study evaluates the safety and tolerability of the investigational treatment. Researchers are looking to understand how patients respond to the treatment in terms of safety and any potential effects it may have.

  • Who can participate: Adults aged 18 to 75 with advanced pancreatic cancer and a specific genetic mutation may be eligible, having previously received certain chemotherapy treatments and meeting specific health criteria.
  • Study details: Participants will receive an investigational medication through an injection.
  • Study timelines: The study will last up to 2 years.
Print
Study details
    Pancreatic Cancer

NCT06898385

Sun Yat-sen University

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.